Vident Investment Advisory’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Vident Investment Advisory’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-399,127	Closed	-$463K	–	1383
2022 Q2	$463K	Buy	399,127 +38,194	+11%	+$39.9K	0.01%	887
2022 Q1	$390K	Buy	360,933 +144,872	+67%	+$109K	0.01%	1007
2021 Q4	$156K	Buy	216,061 +10,129	+5%	+$8.19K	﹤0.01%	1163
2021 Q3	$185K	Buy	+205,932	New	+$248K	0.01%	1095

Vident Investment Advisory's MBII Position: Q3 2022 in Review

Vident Investment Advisory sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 399,127 shares — an estimated $463K sold.

Vident Investment Advisory first reported a position in MBII in Q3 2021 and held it in 4 quarters. The position peaked at $463K in Q2 2022. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.

Vident Investment Advisory reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
Vident Investment Advisory sold 399,127 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $463K.
Vident Investment Advisory first reported a position in Marrone Bio Innovations, Inc. in Q3 2021 and held it in 4 quarters.
Vident Investment Advisory's Marrone Bio Innovations, Inc. position peaked at $463K in Q2 2022.
0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.

Based on Vident Investment Advisory's 13F filing for Q3 2022, filed 14 Nov 2022.